Sonnet BioTherapeutics Holdings Inc logo

Sonnet BioTherapeutics Holdings Inc

FRA:H3D (USA)   Ordinary Shares
€ 5.41 (0%) Feb 14
At Loss
Market Cap:
€ 4.59M ($ 4.73M)
Enterprise V:
€ 2.65M ($ 2.74M)
Volume:
-
Avg Vol (2M):
-
Trade In:

Sonnet BioTherapeutics Holdings Inc (FRA:H3D) Stock News, Headlines & Updates

Sonnet BioTherapeutics Holdings Inc Stock News from GuruFocus

Total 10
  • 1
Dec 23, 2024
Dec 17, 2024
Dec 09, 2024
Dec 04, 2024
Nov 12, 2024
Nov 06, 2024
Oct 17, 2024
Oct 09, 2024
Total 10
  • 1
Show
Entries

Headlines

Total 0
  • 1
No recent news